A61K 51/081
The protein being an albumin
Official title: {the protein being an albumin, e.g. human serum albumin [HSA], bovine serum albumin [BSA], ovalbumin}
A61K51/081 (The protein being an albumin) appears on 80 US grants and 65 published applications in this corpus.
Search patents in A61K- Granted patents
- 80
- Published applications
- 65
- Assignees
- 80
- Inventors
- 273
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 3 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 0 | 0 |
| 1991 | 3 | 0 |
| 1992 | 4 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 3 | 0 |
| 2003 | 0 | 0 |
| 2004 | 2 | 1 |
| 2005 | 1 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 2 | 2 |
| 2009 | 0 | 1 |
| 2010 | 0 | 3 |
| 2011 | 1 | 3 |
| 2012 | 1 | 1 |
| 2013 | 1 | 6 |
| 2014 | 2 | 2 |
| 2015 | 4 | 2 |
| 2016 | 2 | 5 |
| 2017 | 0 | 4 |
| 2018 | 2 | 0 |
| 2019 | 3 | 3 |
| 2020 | 2 | 5 |
| 2021 | 2 | 3 |
| 2022 | 2 | 5 |
| 2023 | 2 | 2 |
| 2024 | 0 | 4 |
| 2025 | 2 | 7 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cleavable radioligands for targeting cell surface receptors and uses thereof7 Jul 2026US 12,673,122 B2Full-Life Technologies UK Limited
- Radiopharmaceutical conjugate compound for diagnosis and/or therapeutic uses thereof3 Feb 2026US 12,539,339 B2Jubilant Draximage Inc.
- Cleavable radioligands for targeting cell surface receptors and uses thereof4 Feb 2025US 12,214,059 B2Full-Life Technologies HK Limited
- Alpha emitter compositions and methods14 Jan 2025US 12,194,111 B2Nant Holdings IP, LLC
- Oncolytic poliovirus for human tumors14 Nov 2023US 11,813,298 B2Duke University
- Cleavable radioligands for targeting cell surface receptors and uses thereof1 Oct 2026US 2026/0295099 A1Full-Life Technologies UK Limited
- Albumin conjugates and process for preparation thereof11 Jun 2026US 2026/0158180 A1Jubilant Draximage Inc.
- Phytic acid-based ternary complex biomimetic nanomaterial, and preparation method and use thereof23 Apr 2026US 2026/0108641 A1The Second Hospital of Tian Jin Medical University
- Nanoplatform for targeting inflammatory macrophages, and composition containing same for preventing or treating inflammatory diseases18 Dec 2025US 2025/0381280 A1Clichembio, Inc
- Albumin nanocomposite comprising phytochemical and composition for improving muscle disease containing same4 Dec 2025US 2025/0367305 A1Seoul National University R&Db Foundation
Most cited
By later US patents
- Polychelants containing macrocyclic chelant moieties92US 5,364,613 A1994
- Amines coupled wth dicyclic dianhydrides capable of being radiolabeled product70US 4,479,930 ATrustees of the University of Massachusetts · 1984
- Labeling proteins with 99m-Tc by ligand exchange57US 4,305,922 AUniversity Patents, Inc. · 1981
- Radionuclide antibody coupling35US 4,877,868 ANeoRx Corporation · 1989
- Polychelants35US 6,274,713 B1Salutar, Inc. · 2001